Form 4 for PRLB Proto Labs Inc
Accepted 2021-11-22 00:00:00 ET · period of report 2021-11-15 · accession 0001437749-21-027225 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-11-22 | 2021-11-15 | PRLB | Greiner Stacy | Dir | A - Grant | $0.00 | +3,255 | 767 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | A | A | 2,488 | $0.00 | 3,255 | D | — | — | (F2) The deferred stock units vest in full on November 15, 2021, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. |
| 2 | Common | Common Stock | 2021-11-15 | A | A | 767 | $0.00 | 767 | D | — | — | (F1) The deferred stock units vest in full on May 18, 2022, but must be retained by the reporting person until the completion of the reporting person's service on the Board of Directors of Proto Labs, Inc. |